198 related articles for article (PubMed ID: 34404529)
1. GATA2 and marrow failure.
Fabozzi F; Strocchio L; Mastronuzzi A; Merli P
Best Pract Res Clin Haematol; 2021 Jun; 34(2):101278. PubMed ID: 34404529
[TBL] [Abstract][Full Text] [Related]
2. GATA2 deficiency.
Hsu AP; McReynolds LJ; Holland SM
Curr Opin Allergy Clin Immunol; 2015 Feb; 15(1):104-9. PubMed ID: 25397911
[TBL] [Abstract][Full Text] [Related]
3. GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity.
Spinner MA; Sanchez LA; Hsu AP; Shaw PA; Zerbe CS; Calvo KR; Arthur DC; Gu W; Gould CM; Brewer CC; Cowen EW; Freeman AF; Olivier KN; Uzel G; Zelazny AM; Daub JR; Spalding CD; Claypool RJ; Giri NK; Alter BP; Mace EM; Orange JS; Cuellar-Rodriguez J; Hickstein DD; Holland SM
Blood; 2014 Feb; 123(6):809-21. PubMed ID: 24227816
[TBL] [Abstract][Full Text] [Related]
4. GATA 2 Deficiency: Focus on Immune System Impairment.
Fabozzi F; Mastronuzzi A; Ceglie G; Masetti R; Leardini D
Front Immunol; 2022; 13():865773. PubMed ID: 35769478
[TBL] [Abstract][Full Text] [Related]
5. GATA2 deficiency and human hematopoietic development modeled using induced pluripotent stem cells.
Jung M; Cordes S; Zou J; Yu SJ; Guitart X; Hong SG; Dang V; Kang E; Donaires FS; Hassan SA; Albitar M; Hsu AP; Holland SM; Hickstein DD; Townsley D; Dunbar CE; Winkler T
Blood Adv; 2018 Dec; 2(23):3553-3565. PubMed ID: 30538114
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hematopoietic cell transplantation in the management of GATA2 deficiency and pulmonary alveolar proteinosis.
van Lier YF; de Bree GJ; Jonkers RE; Roelofs JJTH; Ten Berge IJM; Rutten CE; Nur E; Kuijpers TW; Hazenberg MD; Zeerleder SS
Clin Immunol; 2020 Sep; 218():108522. PubMed ID: 32682923
[TBL] [Abstract][Full Text] [Related]
7. The spectrum of GATA2 deficiency syndrome.
Calvo KR; Hickstein DD
Blood; 2023 Mar; 141(13):1524-1532. PubMed ID: 36455197
[TBL] [Abstract][Full Text] [Related]
8. A Nationwide Study of GATA2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCT.
Jørgensen SF; Buechner J; Myhre AE; Galteland E; Spetalen S; Kulseth MA; Sorte HS; Holla ØL; Lundman E; Alme C; Heier I; Flægstad T; Fløisand Y; Benneche A; Fevang B; Aukrust P; Stray-Pedersen A; Gedde-Dahl T; Nordøy I
J Clin Immunol; 2022 Feb; 42(2):404-420. PubMed ID: 34893945
[TBL] [Abstract][Full Text] [Related]
9. Alveolar Proteinosis, Infectious Complications and Monocytopenia Associated with GATA2 Deficiency.
Raffáč Š; Aljubouri MAS; Gabzdilová J
Neuro Endocrinol Lett; 2021 Jan; 41(6):290-295. PubMed ID: 33714240
[TBL] [Abstract][Full Text] [Related]
10. Successful allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms complicated with secondary pulmonary alveolar proteinosis and Behçet's disease harboring GATA2 mutation.
Sato Y; Fukatsu M; Suzuki T; Sasajima T; Gunji N; Yoshida S; Asano N; Fukuchi K; Mori H; Takano M; Hayashi K; Takahashi H; Shirado-Harada K; Kimura S; Koyama D; Migita K; Ikezoe T
Int J Hematol; 2023 Nov; 118(5):642-646. PubMed ID: 37084069
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic hematopoietic cell transplantation in patients with GATA2 deficiency-a case report and comprehensive review of the literature.
Simonis A; Fux M; Nair G; Mueller NJ; Haralambieva E; Pabst T; Pachlopnik Schmid J; Schmidt A; Schanz U; Manz MG; Müller AMS
Ann Hematol; 2018 Oct; 97(10):1961-1973. PubMed ID: 29947977
[TBL] [Abstract][Full Text] [Related]
12. GATA2 deficiency and haematopoietic stem cell transplantation: challenges for the clinical practitioner.
Bogaert DJ; Laureys G; Naesens L; Mazure D; De Bruyne M; Hsu AP; Bordon V; Wouters E; Tavernier SJ; Lambrecht BN; De Baere E; Haerynck F; Kerre T
Br J Haematol; 2020 Mar; 188(5):768-773. PubMed ID: 31710708
[TBL] [Abstract][Full Text] [Related]
13. WILD syndrome is GATA2 deficiency: A novel deletion in the GATA2 gene.
Dorn JM; Patnaik MS; Van Hee M; Smith MJ; Lagerstedt SA; Newman CC; Boyce TG; Abraham RS
J Allergy Clin Immunol Pract; 2017; 5(4):1149-1152.e1. PubMed ID: 28373026
[No Abstract] [Full Text] [Related]
14. GATA2 Deficiency in Adult Life Is Characterized by Phenotypic Diversity and Delayed Diagnosis.
Shamriz O; Zahalka N; Simon AJ; Lev A; Barel O; Mor N; Tal Y; Segel MJ; Somech R; Yonath H; Toker O
Front Immunol; 2022; 13():886117. PubMed ID: 35603181
[TBL] [Abstract][Full Text] [Related]
15. GATA2 Deficiency: Predisposition to Myeloid Malignancy and Hematopoietic Cell Transplantation.
Rajput RV; Arnold DE
Curr Hematol Malig Rep; 2023 Aug; 18(4):89-97. PubMed ID: 37247092
[TBL] [Abstract][Full Text] [Related]
16. GATA2 Related Conditions and Predisposition to Pediatric Myelodysplastic Syndromes.
Bruzzese A; Leardini D; Masetti R; Strocchio L; Girardi K; Algeri M; Del Baldo G; Locatelli F; Mastronuzzi A
Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066218
[TBL] [Abstract][Full Text] [Related]
17. Germline GATA2 Mutation and Bone Marrow Failure.
McReynolds LJ; Calvo KR; Holland SM
Hematol Oncol Clin North Am; 2018 Aug; 32(4):713-728. PubMed ID: 30047422
[TBL] [Abstract][Full Text] [Related]
18. GATA2 deficiency and MDS/AML: Experimental strategies for disease modelling and future therapeutic prospects.
Kotmayer L; Romero-Moya D; Marin-Bejar O; Kozyra E; Català A; Bigas A; Wlodarski MW; Bödör C; Giorgetti A
Br J Haematol; 2022 Nov; 199(4):482-495. PubMed ID: 35753998
[TBL] [Abstract][Full Text] [Related]
19. Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency.
Kozyra EJ; Pastor VB; Lefkopoulos S; Sahoo SS; Busch H; Voss RK; Erlacher M; Lebrecht D; Szvetnik EA; Hirabayashi S; Pasaulienė R; Pedace L; Tartaglia M; Klemann C; Metzger P; Boerries M; Catala A; Hasle H; de Haas V; Kállay K; Masetti R; De Moerloose B; Dworzak M; Schmugge M; Smith O; Starý J; Mejstrikova E; Ussowicz M; Morris E; Singh P; Collin M; Derecka M; Göhring G; Flotho C; Strahm B; Locatelli F; Niemeyer CM; Trompouki E; Wlodarski MW;
Leukemia; 2020 Oct; 34(10):2673-2687. PubMed ID: 32555368
[TBL] [Abstract][Full Text] [Related]
20. MonoMAC Syndrome Caused by a Novel GATA2 Mutation Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation.
Moraes-Fontes MF; Caramalho Í; Hsu AP; Holland SM; Abecasis M
J Clin Immunol; 2019 Jan; 39(1):4-6. PubMed ID: 30478525
[No Abstract] [Full Text] [Related]
[Next] [New Search]
